Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.52 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.46 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23222393 | 0.92 | CYP1A2 (0.56) | CYP1A2CYP2C19KDM4ESMN1; SMN2SLC9A1 | |
| SCHEMBL4945642 | 0.84 | SLC9A1 (0.57) | CYP1A2CYP2C19KDM4ESLC9A1NR4A1 | |
| SCHEMBL23091227 | 0.84 | CYP1A2 (0.59) | CYP1A2CYP2C19KDM4ESMN1; SMN2SLC9A1 | |
| SCHEMBL23222428 | 0.83 | KDM4E (0.60) | CYP1A2CYP2C19KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL23091158 | 0.83 | KDM4E (0.62) | CYP1A2CYP2C19KDM4ESMN1; SMN2C3AR1 | |
| SCHEMBL23091178 | 0.80 | CYP1A2 (0.65) | CYP1A2CYP2C19KDM4ESMN1; SMN2SLC9A1 | |
| SCHEMBL23091209 | 0.79 | KDM4E (0.57) | CYP1A2CYP2C19KDM4ESMN1; SMN2PTPN1 | |
| SCHEMBL23091202 | 0.79 | MMP13 (0.60) | CYP1A2CYP2C19KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL23091245 | 0.78 | KDM4E (0.60) | CYP1A2CYP2C19KDM4ESMN1; SMN2PTPN1 | |
| SCHEMBL23091271 | 0.78 | KDM4E (0.56) | CYP1A2CYP2C19KDM4ESMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3805210-B1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC (KR) | 2023-11-29 | — | — | EP | claimed |
| CN-112004807-B | Compounds and pharmaceutical compositions comprising the same | 自体吞噬科学有限公司 | 2023-07-18 | — | — | CN | claimed |
| US-11407744-B2 | Compound and pharmaceutical composition comprising same | Autophagysciences Inc. (KR) | 2022-08-09 | — | — | US | claimed |
| EP-3805210-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences, Inc (KR) | 2021-04-14 | — | — | EP | claimed |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences Inc. (KR) | 2021-03-18 | — | — | US | claimed |
| EP-3805210-B1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC (KR) | 2023-11-29 | — | — | EP | disclosed |
| CN-112004807-B | Compounds and pharmaceutical compositions comprising the same | 自体吞噬科学有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-11407744-B2 | Compound and pharmaceutical composition comprising same | Autophagysciences Inc. (KR) | 2022-08-09 | — | — | US | disclosed |
| EP-3805210-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences, Inc (KR) | 2021-04-14 | — | — | EP | disclosed |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences Inc. (KR) | 2021-03-18 | — | — | US | disclosed |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences Inc. (KR) | 2021-03-18 | — | — | US | disclosed |
| CN-112004807-A | Novel compounds and pharmaceutical compositions comprising said compounds | 自体吞噬科学有限公司 | 2020-11-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11407744-B2 | Compound and pharmaceutical composition comprising same | TFEB, ATG7, BECN1 | CYP1A2 4347/4885CYP2C19 4643/4885KDM4E 3653/4885 |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | TFEB, ATG7, BECN1 | CYP1A2 4544/4885CYP2C19 4772/4885KDM4E 3445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.